BR9809354A - Uso de hialuronato de zinco contra úlcera péptica - Google Patents

Uso de hialuronato de zinco contra úlcera péptica

Info

Publication number
BR9809354A
BR9809354A BR9809354-1A BR9809354A BR9809354A BR 9809354 A BR9809354 A BR 9809354A BR 9809354 A BR9809354 A BR 9809354A BR 9809354 A BR9809354 A BR 9809354A
Authority
BR
Brazil
Prior art keywords
peptic ulcer
against peptic
zinc hyaluronate
zinc
hyaluronate against
Prior art date
Application number
BR9809354-1A
Other languages
English (en)
Inventor
Gyula Szporny
Janos Illes
Judit Matuz
Erzsebet Neszmelyi
Garbone Forrai
Bela Stefko
Katalin Saghy
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of BR9809354A publication Critical patent/BR9809354A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

<B>USO DE HIALURONATO DE ZINCO CONTRA úLCERA PéPTICA<D> A invenção refere-se a composições farmacêuticas contra úlcera péptica bem como a um processo para a sua preparação. As composições farmacêuticas da invenção compreendem associado de zinco (complexo) de ácido hialurónico como ingrediente ativo em mistura com um veículo e/ou outros aditivos comumente utilizados na indústria farmacêutica.
BR9809354-1A 1997-04-29 1998-04-28 Uso de hialuronato de zinco contra úlcera péptica BR9809354A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9700826A HU225991B1 (en) 1997-04-29 1997-04-29 Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer
PCT/HU1998/000044 WO1998048815A1 (en) 1997-04-29 1998-04-28 Use of zinc hyaluronate against peptic ulcer

Publications (1)

Publication Number Publication Date
BR9809354A true BR9809354A (pt) 2000-07-04

Family

ID=89995068

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809354-1A BR9809354A (pt) 1997-04-29 1998-04-28 Uso de hialuronato de zinco contra úlcera péptica

Country Status (27)

Country Link
US (1) US6656921B1 (pt)
EP (1) EP1017403B1 (pt)
JP (1) JP2001522361A (pt)
KR (1) KR100572190B1 (pt)
CN (1) CN1126548C (pt)
AT (1) ATE320814T1 (pt)
BG (1) BG64458B1 (pt)
BR (1) BR9809354A (pt)
CA (1) CA2286756C (pt)
CZ (1) CZ297317B6 (pt)
DE (1) DE69833937T2 (pt)
DK (1) DK1017403T3 (pt)
EA (1) EA002134B1 (pt)
EE (1) EE04953B1 (pt)
ES (1) ES2259813T3 (pt)
HK (1) HK1025250A1 (pt)
HU (1) HU225991B1 (pt)
IL (1) IL132214A0 (pt)
NO (1) NO328313B1 (pt)
NZ (1) NZ500978A (pt)
PL (1) PL189526B1 (pt)
PT (1) PT1017403E (pt)
SK (1) SK284864B6 (pt)
TW (1) TW501927B (pt)
UA (1) UA62964C2 (pt)
WO (1) WO1998048815A1 (pt)
ZA (1) ZA983626B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU225991B1 (en) 1997-04-29 2008-02-28 Richter Gedeon Nyrt Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer
ITPD980168A1 (it) * 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Composizioni biocompatibili e biodegradabili comprendenti acido ialuronico e suoi derivati per il trattamento delle ulcere dell'appara
HUP0303779A2 (en) * 2003-11-20 2006-02-28 Richter Gedeon Vegyeszet Pharmaceutical compositions containing hyaluronan complex for the treatment of sclerosis multiplex
US8057294B2 (en) * 2005-09-09 2011-11-15 Wms Gaming Inc. Wagering game system with community gaming system
CN100355790C (zh) * 2005-11-04 2007-12-19 山东福瑞达生物化工有限公司 一种透明质酸锌的制备方法
CN100348621C (zh) * 2005-12-02 2007-11-14 凌沛学 透明质酸铋及其制备方法和应用
CN1329414C (zh) * 2005-12-02 2007-08-01 凌沛学 透明质酸铋钾及其制备方法和应用
CN101023961B (zh) * 2006-02-23 2010-07-21 山东省生物药物研究院 一种含透明质酸钠和锌盐的药物组合物
ITMI20061132A1 (it) * 2006-06-13 2007-12-14 Sinclair Pharmaceuticals Ltd Composizioni topiche antimicrobiche comprendenti lattoferrina, acido ialuronico o suoi sali ed estratti vegetali
TWI516269B (zh) * 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病（ｉｂｄ）治療和預防之透明質酸混合物
TWI383796B (zh) 2009-08-14 2013-02-01 Holy Stone Healthcare Co Ltd Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer
HUP0900717A3 (en) 2009-11-18 2012-02-28 Richter Gedeon Nyrt Pharmaceutical composition for urological use containing zinc hyaluronate
US8722644B2 (en) 2010-01-04 2014-05-13 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
US20110166099A1 (en) * 2010-01-04 2011-07-07 Wu Tsung-Chung Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
ES2388281B1 (es) * 2010-12-27 2013-10-01 Laboratorios Viñas S.A. Composición farmacéutica que comprende ácido hialurónico y un compuesto de zinc y pastilla con palito y procedimiento para preparación correspondientes
JP6095014B2 (ja) * 2012-03-01 2017-03-15 キユーピー株式会社 浮腫抑制用経口剤
US20160287627A1 (en) * 2013-11-22 2016-10-06 Kewpie Corporation Method for suppressing onset of gastric ulcer as adverse effect of drug, oral pharmaceutical composition for suppressing onset of gastric ulcer and method for producing the same
CN104262499A (zh) * 2014-09-03 2015-01-07 佐源集团有限公司 一种低聚果糖锌及含有低聚果糖锌的口服液
CN108051553A (zh) * 2017-12-29 2018-05-18 武汉轻工大学 一种仔猪肠道功能保护剂的筛选方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
EP0259485A4 (en) * 1986-03-14 1988-07-29 Bio Technology General Corp HEAVY METAL SALTS OF HYALURONIC ACID FOR USE AS AN ANTIMICROBIAL AGENT.
US5472950A (en) 1989-02-24 1995-12-05 Richter Gedeon Vegyeszeti Gyar Rt. Compositions containing cobalt hyaluronic acid complex
HU203372B (en) 1989-02-24 1991-07-29 Richter Gedeon Vegyeszet Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient
US6458774B1 (en) * 1989-02-24 2002-10-01 Richter Gedeon Vegyeszeti Gyar Rt. Compositions containing hyaluronic acid associates and a process for preparing same
JPH0648950A (ja) * 1992-07-30 1994-02-22 Taito Kk 抗潰瘍剤
HU225329B1 (en) * 1996-09-12 2006-09-28 Richter Gedeon Vegyeszet Use of zinc or cobalt hyaluronate associate for the manufacture of pharmaceutical compositions of antimicrobial activity
HU225991B1 (en) 1997-04-29 2008-02-28 Richter Gedeon Nyrt Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer

Also Published As

Publication number Publication date
NO995229L (no) 1999-12-22
PT1017403E (pt) 2006-07-31
EP1017403A1 (en) 2000-07-12
EP1017403B1 (en) 2006-03-22
DE69833937T2 (de) 2007-06-06
EA002134B1 (ru) 2001-12-24
EA199900983A1 (ru) 2000-08-28
CZ382799A3 (cs) 2000-03-15
JP2001522361A (ja) 2001-11-13
WO1998048815A1 (en) 1998-11-05
CN1254285A (zh) 2000-05-24
HUP9700826A1 (hu) 1998-12-28
SK146899A3 (en) 2000-06-12
DK1017403T3 (da) 2006-07-31
PL336482A1 (en) 2000-06-19
CA2286756C (en) 2008-02-19
KR100572190B1 (ko) 2006-04-18
HU225991B1 (en) 2008-02-28
IL132214A0 (en) 2001-03-19
HK1025250A1 (en) 2000-11-10
NO328313B1 (no) 2010-01-25
BG64458B1 (bg) 2005-03-31
SK284864B6 (sk) 2006-01-05
US6656921B1 (en) 2003-12-02
ATE320814T1 (de) 2006-04-15
NZ500978A (en) 2001-05-25
ES2259813T3 (es) 2006-10-16
BG103822A (en) 2000-04-28
HU9700826D0 (en) 1997-06-30
EE04953B1 (et) 2008-02-15
UA62964C2 (en) 2004-01-15
CA2286756A1 (en) 1998-11-05
KR20010020413A (ko) 2001-03-15
DE69833937D1 (de) 2006-05-11
PL189526B1 (pl) 2005-08-31
NO995229D0 (no) 1999-10-26
ZA983626B (en) 1998-11-05
CN1126548C (zh) 2003-11-05
TW501927B (en) 2002-09-11
EE9900470A (et) 2000-06-15
CZ297317B6 (cs) 2006-11-15

Similar Documents

Publication Publication Date Title
BR9809354A (pt) Uso de hialuronato de zinco contra úlcera péptica
BR0116402A (pt) Derivados de tetrahidropiridina, sua preparação e sua utilização como inibidores de proliferação celular
AU3435497A (en) Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies
EE03869B1 (et) Sulfiinhappe derivaadid, nende valmistamine ja kasutamine
ATE210943T1 (de) Ophthalmologisches abgabesystem
BR9712314A (pt) Método de uso de inibidores de ciclooxigenase-2 no tratamento e prevenção de neoplasia
MY113825A (en) Use of b-cyclodextrin and a method for improving thickeners for aqueous systems
ATE254922T1 (de) Pharmazeutische zusammensetzungen mit antimikrobieller wirkung
BRPI0009446B8 (pt) composto derivado de pirimido [6,1-a] isoquinolin-4-ona, processo para preparar p mesmo, composição, e, uso de um composto
BR9909468A (pt) Composto anti-bacteriano, composição oral anti-placas, e, processo para promoção da higiene oral
DK0885881T3 (da) Sulfonylalkanoylaminohydroxyethylaminosulfaminsyrer, der er anvendelige som retrovirale proteaseinhibitorer
ATE239709T1 (de) Racemisches huperzin a
DE69431162T2 (de) Fenbendazolformulierungen
ES2104133T3 (es) Composiciones cosmeticas o farmaceuticas que contienen glicerofosfolipidos desacilados para uso topico.
ES2026754A6 (es) Procedimiento de obtencion de una composicion para el tratamiento cosmetico de la piel y del cuerpo.
DE3560313D1 (en) Improvements in or relating to anticonvulsant agents
PT90085A (pt) Processo para a preparacao de composicoes farmaceuticas contendo um complexo organico de ouro para aplicacao topica
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
AU3865289A (en) Cosmetic compositions based on chromone-carboxylate
IT8921513A0 (it) Derivati dell&#39;acido piroglutammico, loro preparazioni e composizioni farmacuetiche che li contengono.
SE9302203L (sv) Komposition för topisk administration av bispilokarpinsyradiestrar till ögat i form av en vattenlösning
EP0666841A1 (en) SUCCINOYLHYDROXYÄTHYLAMINOSULFAMID ACID DERIVATIVES AND THEIR USE AS RETROVIRAL PROTEASE INHIBITORS.
BR9801724A (pt) Composto, processo para sua preparação, composição herbicida e uso do composto.
KR950700685A (ko) 최음제로서 사용되는 요드화수소산(use of hydriodic acid as an aphrodisiac)
BRPI0417170A (pt) composições, solução e métodos para uso e produção destas

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADO DE INT.CL: A61K 31/728; A61P 1/04

Ipc: A61K 31/728 (2008.01), A61P 1/04 (2008.01)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]